Newsletter 141 – Dengue: Takeda’s vaccine is approved in Brazil
The granting of the registration by Anvisa allows the commercialization of the product in the country, as long as the approved conditions are maintained
14/04/2023The granting of the registration by Anvisa allows the commercialization of the product in the country, as long as the approved conditions are maintained
